Cordycepin ameliorates synaptic dysfunction and dendrite morphology
impairments induced by cerebral ischemia via A1R in vitro and in vivo
Abstract
Background and Purpose: Cordycepin has been proved to have
neuroprotective efficacies and to improve learning and memory in
cerebral ischemia. However, the potential mechanisms are unclear so far.
Plasticity of synaptic structure and function is considered as the
neural mechanisms of learning and memory. Therefore, we investigated the
effects of cordycepin on dendritic morphology and synaptic function in
cerebral ischemic models. Experimental Approach: The impact of
cordycepin was studied using oxygen glucose deprivation (OGD) and global
cerebral ischemia (GCI) model. Synaptic transmission and behavioral
long-term potentiation (LTP) were investigated with electrophysiological
recording. Hippocampal dendritic morphology was assessed by Golgi
staining. The density of adenosine A1 and A2A receptors (A1R and A2AR)
evaluated with western blot and immunofluorescence. Key Results:
Cordycepin alleviated the ischemia-induced damages of dendritic
morphology and behavioral LTP in hippocampal CA1 area, improved the
learning and memory ability and up-regulated the expression of A1R but
not A2AR in hippocampus of GCI rats. Besides, cordycepin pre-perfusion
could significantly attenuate the hippocampal slices injury and synaptic
transmission impairment induced by OGD, improved adenosine content and
reduced the expression level of A1R but did not alter A2AR. Furthermore,
the protection of cordycepin on synaptic transmission against ischemic
inhibition was eliminated by using the antagonists of A1R instead of
A2AR. Conclusion and Implications: These findings indicated that
cordycepin alleviated synaptic dysfunction and dendritic injury in vivo
and in vitro ischemia models by modulating adenosine A1R, which may be
the neural mechanisms of cordycepin to improve learning and memory in
cerebral ischemic animals.